C. Comstock

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
C. Comstock, Ch Comstock, Christine H Comstock, C H Comstock, Christine Comstock, Christine H. Comstock, C. H. Comstock
Publication record
163 papers · 9,971 citations · H-index 47

PAPERS

The antenatal diagnosis of placenta accreta
2014187 citationsauthor #1
Re: Cesarean scar pregnancy is a precursor of morbidly adherent placenta. I. E. Timor‐Tritsch, A. Monteagudo, G. Cali, A. Vintzileos, R. Viscarello, A. Al‐Khan, S. Zamudio, P. Mayberry, M. M. Cordoba and P. Dar. Ultrasound Obstet Gynecol 2014; 44: 346–353
20142 citationsauthor #1
Clinical significance of amniotic fluid sludge in twin pregnancies with a short cervical length.
201425 citationsauthor #5
Vasa Previa: Clinical Presentations, Outcomes, and Implications for Management
201396 citationsauthor #10
Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) of the Placenta
20110 citationsauthor #1
The antenatal diagnosis of placental attachment disorders
201169 citationsauthor #1
Comparison of cardiac Z‐score with cardiac asymmetry for prenatal screening of congenital heart disease
201118 citationsauthor #4
Coping with changes in health care.
20110 citationsauthor #1
Collaborative Study on 4‐Dimensional Echocardiography for the Diagnosis of Fetal Heart Defects
201032 citationsauthor #3
Influence of maternal BMI on genetic sonography in the FaSTER trial
2010123 citationsauthor #6
Rupture of the fetal abdomen in prune belly syndrome
20093 citationsauthor #1
Preconceptional Folate Supplementation and the Risk of Spontaneous Preterm Birth: A Cohort Study
2009168 citationsauthor #5
Prenatal Diagnostic Challenges and Pitfalls for Schizencephaly
200911 citationsauthor #2
Role of Second-Trimester Genetic Sonography After Down Syndrome Screening
2009105 citationsauthor #8
INFLUENCE OF MATERNAL BMI ON GENETIC SONOGRAPHY 15 obesity on the quality of prenatal fetal sonographic surveillance
20090 citationsauthor #6
Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial
200950 citationsauthor #6
Collaborative study on 4-dimensional echocardiography for the diagnosis of fetal heart defects: the COFEHD study.
200933 citationsauthor #3
Paradoxical Motion
20095 citationsauthor #1
Effect of a low‐lying placenta on delivery outcome
200956 citationsauthor #6
Contingent screening for Down syndrome—results from the FaSTER trial
200887 citationsauthor #6
Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two‐vessel cord, and hydrocele
20087 citationsauthor #9
296: Fetal macrosomia increases risk of stillbirth
20083 citationsauthor #5
297: Preconceptional folate reduces perinatal mortality and morbidity
20080 citationsauthor #5
Contingent screening for Down syndrome
20082 citationsauthor #6
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.
200842 citationsauthor #7
Individualized Norms of Optimal Fetal Growth: Fetal Growth Potential
200873 citationsauthor #7
Fetal Mediastinal Lymphangiomas
200811 citationsauthor #1
121: Extremes of fetal growth are associated with spontaneous preterm birth
20070 citationsauthor #5
First- and Second-Trimester Screening: Detection of Aneuploidies Other Than Down Syndrome
200784 citationsauthor #7
First- and Second-Trimester Evaluation of Risk for Down Syndrome
2007101 citationsauthor #5
The Ultrasound Diagnosis of Placenta Accreta
20072 citationsauthor #1
28: Combining first and second trimester Down syndrome screening results: A simple, effective approximation
20070 citationsauthor #6
OC173: Global ventricular performance: a new parameter of fetal cardiac function using Velocity Vector Imaging™
20071 citationsauthor #3
Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study
2007208 citationsauthor #6
587: Assessment of risk for birth weight < 5th percentile for gestational age by maternal characteristics with nuchal translucency and maternal serum markers
20070 citationsauthor #7
The Contribution of Birth Defects to Preterm Birth and Low Birth Weight
200767 citationsauthor #9
5: Preconceptional folate prevents preterm delivery
200710 citationsauthor #5
33: Assessment of risk for fetal loss by maternal characteristics with first and second trimester maternal serum markers
20071 citationsauthor #7
The effect of low body mass index on the development of gestational hypertension and preeclampsia
200740 citationsauthor #7
Nuchal Translucency and the Risk of Congenital Heart Disease
200750 citationsauthor #6
P45.03: Fetal cardiac ventricular strain using velocity vector imaging
20070 citationsauthor #3
Human sexual size dimorphism in early pregnancy.
200775 citationsauthor #6
Fetal Homologue of Infant Crying
20060 citationsauthor #1
In reply [5]
20062 citationsauthor #6
Repeated measures screening for Trisomy 21 - results from a general population screening trial (the faster trial)
20060 citationsauthor #6
Faster growth of male fetuses in first trimester of pregnancy
20065 citationsauthor #6
Isolated Choroid Plexus Separation on Second‐Trimester Sonography
20067 citationsauthor #5
Comparison of Serum Markers in First-Trimester Down Syndrome Screening
200649 citationsauthor #8
OP01.12: Maternal age‐specific detection rates and false‐positive rates for first‐ and second‐trimester screening for Down syndrome
20060 citationsauthor #5
Pregnancy Loss Rates After Midtrimester Amniocentesis
2006178 citationsauthor #9
Pregnancy Outcomes With Increased Nuchal Translucency After Routine Down Syndrome Screening
20060 citationsauthor #1
First‐ and second‐trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study
200667 citationsauthor #7
Assisted reproductive technology and pregnancy outcome. Authors' reply
20060 citationsauthor #9
Assessment of risk for preeclampsia requiring delivery prior to 34 weeks gestation by maternal characteristics with first and second trimester maternal serum markers
20060 citationsauthor #7
In reply [6]
20060 citationsauthor #4
Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
200668 citationsauthor #1
Preconception multivitamin or folic acid consumption and pregnancy outcome: A population-based screening study
20060 citationsauthor #7
Early Access to Prenatal Care: Implications for Racial Disparity in Perinatal Mortality
2006135 citationsauthor #6
Early pregnancy growth determines low birth weight
20060 citationsauthor #5
Influence of maternal BMI on the role of second trimester genetic sonography in the faster trial
20060 citationsauthor #6
Prenatal Diagnosis of Congenital Heart Disease: Where Are We Now?
20068 citationsauthor #2
MoM versus Delta NT: Trisomy-21 risk assessment using nuchal translucency (NT) sonography
20050 citationsauthor #5
Sonographic Evaluation of the Ventricular Cardiac Outflow Tracts
200518 citationsauthor #4
Impact of Maternal Age on Obstetric Outcome
2005897 citationsauthor #6
Contingent screening for trisomy 21 — Results from a general population screening trial
20055 citationsauthor #5
Mild Hypophosphatasia In Utero
20053 citationsauthor #1
Quad Screen as a Predictor of Adverse Pregnancy Outcome
2005245 citationsauthor #9
The Ultrasonographic Appearance of Ovarian Ectopic Pregnancies
2005172 citationsauthor #1
First-trimester or second-trimester screening, or both, for Down's syndrome.
2005976 citationsauthor #5
Maternal smoking and pregnancy outcomes
20051 citationsauthor #7
Is there a nuchal translucency measurement above which there is no added benefit from serum screening
20050 citationsauthor #2
Clinical Implications of the Prenatal Sonographic Finding of Fetal Myocardial Echogenic Foci
20057 citationsauthor #4
First-trimester septated cystic hygroma : Prevalence, natural history, and pediatric outcome. Authors' replay
20050 citationsauthor #8
Stillbirth risk prediction
20050 citationsauthor #6
First-trimester septated cystic hygroma: Prevalence, natural history, and pediatric outcome [4] (multiple letters)
20050 citationsauthor #6
First-trimester pregnancy associated plasma protein-A (PAPP-A) levels identify the pregnant smoker at high-risk of pregnancy complications
20051 citationsauthor #7
First-Trimester Septated Cystic Hygroma: Prevalence, Natural History, and Pediatric Outcome
2005207 citationsauthor #4
Prenatal Diagnosis of Herniated Dandy‐Walker Cysts
20058 citationsauthor #3
Antenatal diagnosis of placenta accreta: a review
2005345 citationsauthor #1
Assisted Reproductive Technology and Pregnancy Outcome
2005315 citationsauthor #6
First trimester uterine artery Doppler and subsequent intrauterine growth restriction and preterm birth
20040 citationsauthor #7
Multiple marker first and second trimester serum screening for adverse pregnancy outcome: A FASTER trial study
20040 citationsauthor #8
The effect of maternal smoking on maternal serum analyte levels and down syndrome screen positivity—Results from the FASTER trial
20040 citationsauthor #8
Obesity, obstetric complications and cesarean delivery rate--a population-based screening study.
20041,153 citationsauthor #6
First and second trimester evaluation of risk for down syndrome: A cost-utility analysis - results of the FASTER trial
20040 citationsauthor #5
First and second trimester down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): A FASTER trial study
20040 citationsauthor #7
Racial disparity in perinatal mortality - results from the FASTER trial
20040 citationsauthor #6
First and second trimester evaluation of risk (FASTER) trial: The role of second trimester genetic sonography
200421 citationsauthor #5
The effect of vaginal bleeding on maternal serum PAPP-A, free β-hCG, and nuchal translucency. A population based screening study (the FASTER trial)
20041 citationsauthor #8
The effect of maternal prednisone use on second-trimester maternal serum unconjugated estriol levels—Results from the FASTER trial
20040 citationsauthor #8
First and second trimester evaluation of risk (FASTER) trial: Detection of aneuploidies other than down syndrome
20041 citationsauthor #6
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
2004594 citationsauthor #6
The contribution of birth defects to prematurity and low birthweight in a population-based screening study (The FASTER Trial)
20040 citationsauthor #8
Determinants of fetal growth impairment
20040 citationsauthor #6
Second‐Trimester Sonography and Trisomy 18
200425 citationsauthor #5
Sonographic detection of placenta accreta in the second and third trimesters of pregnancy.
2004457 citationsauthor #1
Second‐Trimester Sonography and Trisomy 18
200456 citationsauthor #5
Threatened abortion: A risk factor for poor pregnancy outcome, a population-based screening study.
2004280 citationsauthor #6
First-Trimester Nasal Bone Evaluation for Aneuploidy in the General Population
200440 citationsauthor #4
Nuchal translucency and the risk of congenital heart disease—A population-based screening study (the FASTER trial)
20041 citationsauthor #6

TIMELINE

1979 11 citations

1980 76 citations

1984 9 citations

1985 73 citations

1986 35 citations

1987 58 citations

1988 2 citations

1990 37 citations

1991 97 citations

1992 29 citations

1994 164 citations

1995 133 citations

1996 9 citations

1997 213 citations

1998 35 citations

1999 0 citations

2000 286 citations

2001 32 citations

2002 155 citations

2003 327 citations

2004 2,629 citations

2005 3,200 citations

2006 519 citations

2007 639 citations

2008 225 citations

2009 431 citations

2010 155 citations

2011 87 citations

2013 96 citations

2014 214 citations

C. Comstock

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT